888 related articles for article (PubMed ID: 2342522)
1. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
[TBL] [Abstract][Full Text] [Related]
3. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Cox JV; Steane E; Cunningham G; Frenkel EP
Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
[TBL] [Abstract][Full Text] [Related]
4. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B; Schonewille H; Ndugwa C; Brand A
Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
[TBL] [Abstract][Full Text] [Related]
5. Red cell alloantibodies in patients with haemoglobinopathies.
Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
[TBL] [Abstract][Full Text] [Related]
6. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
[TBL] [Abstract][Full Text] [Related]
7. Transfusion medicine in a developing country - alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia.
Gader AG; Al Ghumlas AK; Al-Momen AK
Transfus Apher Sci; 2008 Dec; 39(3):199-204. PubMed ID: 18951063
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study.
Koshy M; Burd L; Wallace D; Moawad A; Baron J
N Engl J Med; 1988 Dec; 319(22):1447-52. PubMed ID: 3054555
[TBL] [Abstract][Full Text] [Related]
9. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.
Godfrey GJ; Lockwood W; Kong M; Bertolone S; Raj A
Pediatr Blood Cancer; 2010 Dec; 55(6):1134-7. PubMed ID: 20979172
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
11. Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease.
Noizat-Pirenne F
Transfus Clin Biol; 2012 Jun; 19(3):132-8. PubMed ID: 22818360
[TBL] [Abstract][Full Text] [Related]
12. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.
McPherson ME; Anderson AR; Haight AE; Jessup P; Castillejo MI; Hillyer CD; Josephson CD
Transfusion; 2009 Sep; 49(9):1977-86. PubMed ID: 19453984
[TBL] [Abstract][Full Text] [Related]
13. [Transfusion and alloimmunization in sickle cell anemia patients].
Norol F; Nadjahi J; Bachir D; Desaint C; Guillou Bataille M; Beaujean F; Bierling P; Bonin P; Galacteros F; Duedari N
Transfus Clin Biol; 1994; 1(1):27-34. PubMed ID: 8186850
[TBL] [Abstract][Full Text] [Related]
14. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.
Wahl SK; Garcia A; Hagar W; Gildengorin G; Quirolo K; Vichinsky E
Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830
[TBL] [Abstract][Full Text] [Related]
15. [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients].
Diarra AB; Guindo A; Kouriba B; Dorie A; Diabaté DT; Diawara SI; Fané B; Touré BA; Traoré A; Gulbis B; Diallo DA
Transfus Clin Biol; 2013 Dec; 20(5-6):476-81. PubMed ID: 23916574
[TBL] [Abstract][Full Text] [Related]
16. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.
Castro O; Sandler SG; Houston-Yu P; Rana S
Transfusion; 2002 Jun; 42(6):684-90. PubMed ID: 12147019
[TBL] [Abstract][Full Text] [Related]
17. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.
Vichinsky EP; Haberkern CM; Neumayr L; Earles AN; Black D; Koshy M; Pegelow C; Abboud M; Ohene-Frempong K; Iyer RV
N Engl J Med; 1995 Jul; 333(4):206-13. PubMed ID: 7791837
[TBL] [Abstract][Full Text] [Related]
18. Frequency of red cell alloimmunization in patients with sickle cell anemia in an Egyptian referral hospital.
Aly R; El-sharnoby MR; Hagag AA
Transfus Apher Sci; 2012 Dec; 47(3):253-7. PubMed ID: 22980915
[TBL] [Abstract][Full Text] [Related]
19. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.
Vichinsky EP; Luban NL; Wright E; Olivieri N; Driscoll C; Pegelow CH; Adams RJ;
Transfusion; 2001 Sep; 41(9):1086-92. PubMed ID: 11552063
[TBL] [Abstract][Full Text] [Related]
20. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
Schonewille H; van de Watering LM; Brand A
Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
